Lotus Eye Hospital and Institute Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Lotus Eye Hospital and Institute heeft een totaal eigen vermogen van ₹594.1M en een totale schuld van ₹11.1M, wat de schuld-eigenvermogensverhouding op 1.9% brengt. De totale activa en totale passiva bedragen respectievelijk ₹666.3M en ₹72.2M. De EBIT Lotus Eye Hospital and Institute is ₹22.0M waardoor de rentedekking -6.1 is. Het heeft contanten en kortetermijnbeleggingen van ₹69.3M.
Belangrijke informatie
1.9%
Verhouding schuld/eigen vermogen
₹11.10m
Schuld
| Rente dekkingsratio | -6.1x |
| Contant | ₹69.30m |
| Aandelen | ₹594.09m |
| Totaal verplichtingen | ₹72.18m |
| Totaal activa | ₹666.27m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹140.2M ) LOTUSEYE } overtreffen de korte termijn passiva ( ₹62.3M ).
Langlopende schulden: De kortetermijnactiva LOTUSEYE ( ₹140.2M ) overtreffen de langetermijnschulden ( ₹9.9M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: LOTUSEYE heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van LOTUSEYE is de afgelopen 5 jaar gestegen van 0.2% naar 1.9%.
Schuldendekking: De schuld van LOTUSEYE wordt goed gedekt door de operationele kasstroom ( 511.8% ).
Rentedekking: LOTUSEYE verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.